Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Abstract
In recent years, there has been a plethora of attempts to discover biomarkers that are more reliable than α-fetoprotein for the early prediction and prognosis of hepatocellular carcinoma (HCC). Efforts have involved such fields as genomics, transcriptomics, epigenetics, microRNA, exosomes, proteomics, glycoproteomics, and metabolomics. HCC arises against a background of inflammation, steatosis, and cirrhosis, due mainly to hepatic insults caused...
Paper Details
Title
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Published Date
Jan 28, 2020
Journal
Volume
10
Issue
2
Pages
50 - 50
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History